Skip to Content Facebook Feature Image

Robotic, military dog training featured in China-Russia-Mongolia border defense exercise

China

China

China

Robotic, military dog training featured in China-Russia-Mongolia border defense exercise

2025-09-10 13:29 Last Updated At:14:07

The training of robotic dogs and military dogs was featured in the China-Russia-Mongolia joint border defense exercise which concluded on Tuesday.

Code-named "Border Defense Cooperation 2025," the two-day exercise took place in a frontier area where the three countries meet.

The dog training session was hosted on Russian territory, focusing on six key areas of obstacle navigation, drug search, explosives detection, item identification, pursuit and apprehension, and concealed target search.

Robotic dogs were integrated into the exercise, working alongside military dogs to perform search, detection, and identification tasks.

This joint exercise aimed to strengthen friendship between the border defense forces of the three nations and enhance collective capability to address security threats.

"This joint exercise not only tested our trilateral capacity to respond to emergencies but also is an important step in solidifying the traditional friendship, deepening strategic mutual trust, and enhancing security cooperation among China, Russia, and Mongolia," said Chen Jiang, a participating Chinese soldier.

Robotic, military dog training featured in China-Russia-Mongolia border defense exercise

Robotic, military dog training featured in China-Russia-Mongolia border defense exercise

Robotic, military dog training featured in China-Russia-Mongolia border defense exercise

Robotic, military dog training featured in China-Russia-Mongolia border defense exercise

China on Sunday unveiled an updated version of its national medical insurance drug list and the inaugural edition of the commercial insurance innovative drug list, according to the National Healthcare Security Administration.

The updated national medical insurance drug list has added 114 drugs, among which 50 are innovative pharmaceuticals. It has incorporated certain medications that fill the gaps in basic medical insurance coverage, such as drugs for major diseases, rare diseases, and chronic conditions.

The commercial insurance innovative drug list included 19 drugs for the treatment of tumors, rare diseases, and Alzheimer's, among others.

The country's medical insurance authority has adjusted the list for eight years in a row, increasing the total number of medications to 3,253 and significantly improving coverage in key areas such as oncology, chronic diseases, mental illnesses, rare diseases, and pediatric medications.

China updates national medical insurance catalog, adds 114 new drugs

China updates national medical insurance catalog, adds 114 new drugs

Recommended Articles